Add-on therapy

Drug	Drug Name	Drug Description
DB12159	Dupilumab	A monoclonal antibody used to treat moderate to severe atopic dermatitis, asthma, and nasal polyps accompanied by chronic rhinosinusitis in adolescents and adults.
DB00043	Omalizumab	A monoclonal anti-immunoglobulin E (IgE) antibody used to treat asthma, chronic idiopathic urticaria, chronic rhinosinusitis with nasal polyps, and IgE-mediated food allergy.

Drug	Drug Name	Target	Type
DB12159	Dupilumab	Interleukin-4 receptor subunit alpha	target
DB12159	Dupilumab	Interleukin-13	target
DB12159	Dupilumab	Interleukin-4	target
DB00043	Omalizumab	High affinity immunoglobulin epsilon receptor subunit alpha	target
DB00043	Omalizumab	High affinity immunoglobulin epsilon receptor subunit beta	target

Drug	Drug Name	Phase	Status	Count